Good thoughts and comments, thankyou! The abstract as it stands indicates that 95 CI mOS data needs an extension before we could approach the FDA as the dream team? Good luck to everyone, the talk on the 19th may offer up a cohort that we can get conditional approval for, I'd then feel for the small ASX holders that were backed into a corner and sold before this important readout.
